# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: Laboratory Criteria

Extent: E+W+S+N.I.

Positive results of at least one or more of the following tests or combination of tests:
IgM hepatitis B core antibody (anti-HBc IgM)
Hepatitis B surface antigen (HBsAg)
Hepatitis B e antigen (HBeAg)
Hepatitis B nucleic acid (HBV-DNA)

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.17/division/2 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.17/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.